Table 3 |
||||||
|
Genotype skewing of FCGR3A and FCGR2A gene polymorphisms in anti-GPI antibody positive healthy individuals |
||||||
| Polymorphism |
Genotype |
RA GPI+ (n = 23) |
Healthy GPI+ (n = 9) |
P (χ2) |
P (Fisher's) |
OR (95% CI) |
|
|
||||||
| FCGR3A-158 |
FF |
10 (43.5%) |
8 (88.9%) |
0.019 |
0.044 |
0.09 (0.01–0.89) |
| FV/VV |
13(56.5%) |
1 (11.1%) |
||||
| FCGR2A-131 |
HH |
16 (69.6%) |
4(44.4%) |
0.19 |
0.24 |
2.86 (0.58–13.96) |
| HR/RR |
7 (30.4%) |
5 (55.6%) |
||||
|
|
||||||
|
P values are given for RA versus healthy individuals using a 2×2 contingency table. CI, confidence interval; Fisher's, Fisher's probability test; OR, odds ratio; RA, rheumatoid arthritis. |
||||||
|
Matsumoto et al. Arthritis Research & Therapy 2005 7:R1183 doi:10.1186/ar1802 |
||||||
